Andrew Freese, M.D, Ph.D.
Chief of Neurosurgery at Brandywine Hospital
Andrew Freese, M.D, Ph.D., is the Chief of Neurosurgery at Brandywine Hospital. He received his M.D. from Harvard Medical School and his Ph.D. from the Massachusetts Institute of Technology. He completed his surgical internship, neurosurgical residency and fellowship training at the University of Pennsylvania. Upon completing his training, he joined the Department of Neurosurgery at Thomas Jefferson University, where he was Vice Chairman and Associate Professor, Director of Neurosurgery Research, mentor for the Rothman Institute Orthopaedic Spine Fellowship and a member of the Jefferson Regional Spinal Cord Injury Center. Dr. Freese became a Professor of Neurosurgery at Drexel University College of Medicine and Director of the Graduate Spine Center. Dr. Freese has returned to his roots in the Philadelphia area after serving as Director of Spinal Surgery and Vice Chairman of Neurosurgery at the University of Minnesota, and as Chairman of Neurosurgery at the University of South Carolina.
Dr. Freese is board certified by the American Board of Neurological Surgeons and is actively involved in ongoing neurosurgery research projects. He has published hundreds of research articles, abstracts and book chapters, and has edited several internationally recognized books in clinical neuroscience.
He is renowned for his pioneering work on gene therapy for neurological diseases, including the publication of the first successful transfer of a foreign gene into a mammalian neuron, and the first successful viral-vector gene therapy clinical trial for a neurologic disease.
Chief of Neurosurgery and Neurosurgical Medical Director, Brandywine Hospital, Coatesville, PA (Since 2008)
Director, Brandywine Valley Neurosurgery and Spine, Coatesville, PA
Executive Director, The CNS Gene Therapy Consortium, 1803 Pine Street, Suite 1, Philadelphia, PA 19103
C.E.O., FreeseTEC Corporation, Bryn Mawr, PA 19010